11531286

Source:http://linkedlifedata.com/resource/pubmed/id/11531286

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0019453, umls-concept:C0043210, umls-concept:C0205210, umls-concept:C0282460, umls-concept:C0441771, umls-concept:C0442027, umls-concept:C0677874, umls-concept:C0677886, umls-concept:C1519429
pubmed:issue	2
pubmed:dateCreated	2001-9-4
pubmed:abstractText	The aim of this study was to evaluate the 2-year survival rate in a group of women in complete clinical remission (cCR) from Stage III ovarian cancer following front-line therapy who were then treated with a 6-month course of altretamine.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA04920, http://linkedlifedata.com/resource/pubmed/grant/CA12213, http://linkedlifedata.com/resource/pubmed/grant/CA12644, http://linkedlifedata.com/resource/pubmed/grant/CA13612, http://linkedlifedata.com/resource/pubmed/grant/CA14028, http://linkedlifedata.com/resource/pubmed/grant/CA20319, http://linkedlifedata.com/resource/pubmed/grant/CA22433, http://linkedlifedata.com/resource/pubmed/grant/CA27057, http://linkedlifedata.com/resource/pubmed/grant/CA32102, http://linkedlifedata.com/resource/pubmed/grant/CA35176, http://linkedlifedata.com/resource/pubmed/grant/CA35178, http://linkedlifedata.com/resource/pubmed/grant/CA35192, http://linkedlifedata.com/resource/pubmed/grant/CA35261, http://linkedlifedata.com/resource/pubmed/grant/CA35281, http://linkedlifedata.com/resource/pubmed/grant/CA35431, http://linkedlifedata.com/resource/pubmed/grant/CA37981, http://linkedlifedata.com/resource/pubmed/grant/CA38926, http://linkedlifedata.com/resource/pubmed/grant/CA42777, http://linkedlifedata.com/resource/pubmed/grant/CA45377, http://linkedlifedata.com/resource/pubmed/grant/CA45807, http://linkedlifedata.com/resource/pubmed/grant/CA46368, http://linkedlifedata.com/resource/pubmed/grant/CA46441, http://linkedlifedata.com/resource/pubmed/grant/CA58415, http://linkedlifedata.com/resource/pubmed/grant/CA58686, http://linkedlifedata.com/resource/pubmed/grant/CA58861, http://linkedlifedata.com/resource/pubmed/grant/CA63844, http://linkedlifedata.com/resource/pubmed/grant/CA63850, http://linkedlifedata.com/resource/pubmed/grant/CA68183, http://linkedlifedata.com/resource/pubmed/grant/CA76462, http://linkedlifedata.com/resource/pubmed/grant/CA96429
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0365304
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Altretamine, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/CA-125 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0090-8258
pubmed:author	pubmed-author:AlbertsD SDS, pubmed-author:ChapmanJ AJA, pubmed-author:HanniganE VEV, pubmed-author:HunterV JVJ, pubmed-author:KohlerP CPC, pubmed-author:LiuP YPY, pubmed-author:RothenbergM LML, pubmed-author:TierstenAA, pubmed-author:WeinerS ASA, pubmed-author:WeissG RGR, pubmed-author:WilczynskiSS
pubmed:copyrightInfo	Copyright 2001 Academic Press.
pubmed:issnType	Print
pubmed:volume	82
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	317-22
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:11531286-Administration, Oral, pubmed-meshheading:11531286-Adult, pubmed-meshheading:11531286-Aged, pubmed-meshheading:11531286-Aged, 80 and over, pubmed-meshheading:11531286-Altretamine, pubmed-meshheading:11531286-Antineoplastic Agents, Alkylating, pubmed-meshheading:11531286-Antineoplastic Agents, Phytogenic, pubmed-meshheading:11531286-CA-125 Antigen, pubmed-meshheading:11531286-Drug Administration Schedule, pubmed-meshheading:11531286-Epithelial Cells, pubmed-meshheading:11531286-Female, pubmed-meshheading:11531286-Humans, pubmed-meshheading:11531286-Middle Aged, pubmed-meshheading:11531286-Neoplasm Staging, pubmed-meshheading:11531286-Ovarian Neoplasms, pubmed-meshheading:11531286-Paclitaxel, pubmed-meshheading:11531286-Remission Induction, pubmed-meshheading:11531286-Survival Rate
pubmed:year	2001
pubmed:articleTitle	Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).
pubmed:affiliation	Vanderbilt University Medical Center, Nashville, Tennessee 37232-5536, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II